We’re improving your experience!

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02311920
Title Temozolomide in Combination With Ipilimumab and/or Nivolumab in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Medical Center-Parnassus San Francisco California 94143 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Cleveland Clinic Cancer Center/Fairview Hospital Cleveland Ohio 44111 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field